Answer
Panitumumab (Vectibix) treats adults with wild-type RAS metastatic colorectal cancer: first-line with FOLFOX or FOLFIRI; second-line with FOLFIRI after first-line fluoropyrimidine-based chemotherapy excluding irinotecan; or alone after failure of fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens.
Sources for this answer
- Vectibix 20 mg/mL concentrate for solution for infusionAmgen Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 27Document updated
Sources checked